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The present study describes our experience with CAPD in an unselected group of patients
presenting with endstage renal failure. Twenty-three consecutive patients were offered CAPD,
in-center, and home hemodialysis. Twenty-two patients selected CAPD, including 14 patients
more than 60 years of age, four patients with diabetes, and one with multiple myeloma. CAPD
training was performed in an out-of-hospital office facility. One patient returned to hemodialy-
sis following the development of resistant Pseudomonas peritonitis, two patients died of a
myocardial infarction, and one patient died with a GI bleed. The other 18 patients are doing
well. Assessment of 17 patients maintained on therapy for four months or more revealed that
the patients are less depressed, less organic, and have fewer physical symptoms than previously
reported for a comparable group of patients maintained on hemodialysis for a similar period of
time. In conclusion, CAPD can be successfully employed, at least for the initial months of
therapy, to treat the vast majority of patients with endstage renal disease. CAPD training and
follow-up care can be provided in an out-of-hospital office facility.
INTRODUCTION
Continuous ambulatory peritoneal dialysis (CAPD) was recognized as a practical
treatment modality for patients with endstage renal disease (ESRD) in 1978 [1-3].
During the past two years, refinements in the technical aspects ofthe procedure have
expanded the potential patient population for whom CAPD is now a viable
therapeutic option [4-6]. At the present time, however, it remains unclear what
percentage of the population with ESRD can be seriously considered as candidates
for CAPD. While someinvestigators feel that only 15 to 20 percent ofESRD patients
can be trained for CAPD [4], others feel that the majority can be maintained on this
therapy [5].
During the past 15 months we have had an unique experience with CAPD in the
management of patients with renal failure. All patients presenting to our group with
ESRD were offered CAPD therapy or hemodialysis in the nearest outlying facility
with available resources, because of the lack of available hemodialysis facilities in
New Haven. The lack of long-term experience with CAPD as a therapeutic alterna-
tive was carefully explained to 23 consecutive patients. Nevertheless 22 patients
elected CAPD while only one elected to receive hemodialysis treatments. No patients
were refused CAPD training. Because of the lack of available hospital resources, a
CAPD training facility was established in a specially designated area ofaphysician's
office adjacent to, but physically separate from, the hospital-based dialysis facility.
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The present paper details our experience with this unselected group of 22 patients
with ESRD who received their CAPD training in an out-of-hospital, office facility.
METHODS
During the past 15 months all new patients with ESRD (defined bythe presence of
uremic symptoms and a creatinine clearance < 8 cc/min) were offered CAPD, home
hemodialysis, or in-center hemodialysis as therapeutic options. In-center hemodialy-
sis treatments would have to be obtained by these patients at a distance of25 to 70
miles from their homes because no places were available in the hemodialysis units in
New Haven. Although the potential risks of CAPD were fully explained, 22patients
with ESRD elected CAPD; one elected in-center hemodialysis and none home
hemodialysis. No patients with ESRD were refused CAPD training.
All patients were admitted to the hospital where two-cuffTenckoffcatheters were
surgically inserted. Patients were then dialyzed for 36 continuous hours followed by
6- to 8-hour treatments for two or three successive days. After the last 6- to 8-hour
treatment, patients were discharged from the hospital and CAPD trainingwas begun
within three to five days. Training was performed in a physician's office physically
detached from the hospital, in a separate area designated for CAPD training.
Training consisted of three 1 to I1/2 hour individualtrainingsessions per daycentered
around CAPD "bag changes." Patients were given literature to read and were
instructed in the basic principles and techniques involved in CAPD [1-5]. Patients
were taught how to perform bag changes and give skin care of the catheter exit site
and were given written instructions concerning these procedures. Training was
completed within 14 days for all patients. Patients returned to thetrainingfacility on
a monthly basis for connecting tube changes and physical and laboratory examina-
tions. Each patient's techniques of performing bag exchanges and skin care were
reviewed on a monthly basis. Patients were encouraged to call the training facility
for any problems or difficulties that arose. Since October 1979, the new screw-
lock titanium adapter between the Tenckoff catheter and connecting tube has been
used [6].
Treatment consisted offour exchanges per day, seven days per week, using2,000 cc
plastic bags of standard peritoneal dialysate (Travenol). 1.5 percent dextrose
dialysate was used for most exchanges; 4.25 percent dextrose dialysate was used as
needed to remove excess fluid. Peritonitis was diagnosed by the development of
cloudy fluid associated with abdominal pain and positive peritoneal fluid cultures.
Therapy consisted of the institution of intraperitoneal antibiotics, as previously
described [6]. Cephalothin (250 mg per 2-liter exchange) was the initial antibiotic
used. The number of bag exchanges was increased to six per day until clearing of
peritoneal fluid occurred. Cultures of peritoneal fluid were obtained on all patients
prior to the start of antibiotic therapy and treatment adjusted depending on the
organism identified. Peritonitis was treated out ofhospital; patients were hospitalized
only if they were unable to perform the treatment at home.
Careful and thorough dietary instruction was given to all patients. Patients were
encouraged to eat a minimum of 80 to 100 grams ofprotein and a maximum of 1,500
to 2,000 calories per day, with 30-35 percent of the calories in the form of carbo-
hydrates.
The overall functional and psychological status of the CAPD patients was
assessed, utilizing standardized evaluation procedures previously employed by us in
the assessment of a large cohort of home and in-center hemodialysis patients [8-10].
Only those patients maintained on CAPD for four or more months were examined
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and comparisons were made with patients maintained on hemodialysis for three to
twelve months. The data on the hemodialysis patients is compiled from information
previously obtained [8]. Patients completed two forced-choice questionnaires of the
Kupfer-Detre Systems (KDS). The KDS-1 form evaluates current psychological
status using 41 questions covering a variety of psychological and neurovegetative
symptoms. The KDS-2 form elicits data on presence or absence of 64 specific
physical symptoms. The scoring, standardization, and utility of the questionnaires
are well documented both in healthy controls and in dialysis patients [8-13].
All data are expressed as mean ± SEM and statistical comparisons are made with
student's "t" test or "T" test for proportions.
RESULTS
The 22 patients trained for CAPD are listed in Table 1. Eighteen of these pa-
tients remain at home and are doing well. Three patients have died. One patient
changed to hemodialysis after her peritoneal catheter was removed to facilitate the
cure of a resistant pseudomonas peritonitis. Of particular note is the fact that 14 of
the 22 patients are .60 years of age and five of the patients are over age 70. Five of
the 14 patients .60 years ofage are unmarried and live alone. Training these older
patients to perform CAPD has not presented any major difficulties, although three
patients require visiting nurse assistance to perform skin care.
Theetiology ofthe renalfailure in our CAPD patients is similar to that reported in
larger series of patients with ESRD [8]. Included in the present series are three
patients with diabetic nephropathy, one withmultiple myeloma, and one with biopsy
proven cholesterol embolization.
The incidence ofperitonitis, one infection per seven patient-months, is similar to
that reported in other series of CAPD patients [4-6]. There was not a statistically
significant greater incidence of infection in the patients .60 years of age, or in the
patients with diabetic nephropathy.
Only seven of the patients have required hospitalization for a total of 57 days after
the initial insertion oftheirperitoneal catheters. Patients 2, 4, and 8 were hospitalized
for a total of 21 days for treatment of peritonitis; patient11 was hospitalized for
replacement of his peritoneal catheter, and patient1 was hospitalized for pneumonia.
Patients 13 and 18 were hospitalized preterminally with a gastrointestinal bleed and
an acute myocardial infarction, respectively.
The psychological status of the CAPD patients maintained on therapy for>4
months (patients 1-17) wascompared to agroup ofhemodialysis patients maintained
on therapy for a similarperiod oftime(Table2). Whilethe hemodialysis patients had
a meandepressionscore on theKDS-1 form, 7.5 ±0.3, comparable to that ofpatients
seeking help in an outpatient psychiatric clinic, 7.6 ± 0.4 [12] CAPD patients had
significantly lower scores 3.0 ±0.5(p<0.01). Previous use ofthis questionnaire with
psychiatric outpatients indicated that scores >10 on the depression scale reflected
severe depressive symptomatology [13]; 25 percent of the hemodialysis patients had
scores in this range while none of the CAPD patients did (p<0.01).
Similarly, the CAPD patients had significantly lower organicity scores (3.1 ± 0.5)
than the hemodialysis patients (5.2 ±0.03,p<0.01). Previous studies have suggested
that scores of six or greater are associated with clinical evidence of substantial
organic brain dysfunction [11]. While 40 percent of the hemodialysis patients had
scores over six, only seven percent of the CAPD patients did (p<0.01).
The mean score ofthe hemodialysis patients, 19.1 ±0.3 on the physical symptoms
checklist (KDS-2), are significantly higher than the score of the CAPD patients
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TABLE 1
CAPD Patients
Marital
latient Home
No. Sex Age Diagnosis* Situation
1 M 38 CGN Married
2 F 55 CGN Married
3 F 52 Polycystic Single- lives
alone
4 F 65 Diabetes Widow- lives
with daughter
5 M 69 Polycystic Married
6 M 35 CGN Married
7 F 62 RVT Married
8 M 63 CGN Single-
lives alone
9 F 65 CIN Married
10 M 73 CGN Single-lives
alone
11 M 73 CIN Single- lives
alone
12 M 41 CGN Married
13 F 69 Myeloma Married
14 F 60 Diabetes
15 F 49 CIN
16 F 60 CGN
Married
Married
Married
17 F 40 Polycystic Married
18 F 63 Diabetes Widow-lives
with daughter
19 M 76 CIN Single-lives
alone
20 M 55 Diabetes Married
21 M 72 Cholesterol Married
emboli
22 F 78 CGN Single-
lives alone
No.
Months No.
on Episodes Outcome
CAPD Peritonitis Comment
14 3 Doing well
13 3 Doing well
12 1 Doing well
11 3 Doing well
11 0 Doing well
10 2 Doing well
10 1 Doing well
9 3 Doing well
9 0 Doing well
9 0 Doing well
8 2 Doing well
6 2 Doing well
6 0 DiedofGI
bleed
6 0 Doing well
5 0 Doing well
5 2 Changed to
hemodialysist
4 0 Doing well
3 1 Died of MI
3 0 Doing well
2 0 Doing well
2 0 Died of MI
1 0 Doing well
CGN = chronic glomerulonephritis
RVT = renal vein thrombosis
CIN = Chronic interstitial nephritis
t = Catheter removed because of resistant Pseudomonas peritonitis
7.5 1.3 (p<0.01); while 40 percent of the hemodialysis patients had scores greater
than or equal to 20, only seven percent ofthe CAPD patients had scores in this range
(p<O.Ol).
Monthly laboratory testing on the CAPD patients maintained on treatment for>4
months (patients 1-17) indicates that the mean values of the most recent BUN,
creatinine, albumin, cholesterol, triglycerides, hematocrit, calcium, and phosphorus
determinations are not significantly different than those reported for other groups of
CAPD patients (Table 3) [6]. Since blood and plasma laboratory values may not
come to equilibrium until the patients have been on treatment for six months or more
[6], the mean values in the table probably do not reflect the ultimate equilibrium
values.
P,
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TABLE 2
KDS Scores
CAPD (n = 17) Hemodialysis (n = 46) Controls (see text)*
Depression Score 3.0 i 0.6 7.5 + 0.3' 4.1 X 0.3[9]
Organicity scan 3.1 ; 0.5 5.2 * 0.3' 1.5 i 0.1[9J
Physical symptom checklist 7.5 fi: 1.3 19 + 1.3x 1.6 + 0.418]
Mean age 57 * 3 54 2
xp < 0.01 when compared to CAPD patients
*This group is not strictly comparable to the CAPD group, and is therefore not suitable for statistical
comparison so the scores should be used only to indicate those obtained in normal individuals.
DISCUSSION
CAPD has recently been developed as an alternative therapy for patients with
endstage renal failure[1-6]. At present, there is insufficient experience with CAPD to
compare the long-term effects of this treatment modality with the more standard
hemodialysis and intermittent peritoneal dialysis therapies. Initial results with
CAPD, however, have been promising [1-6]. Nevertheless, it remains unclear at
present what impact CAPD will have on existing ESRD health care programs.
The present study suggests that the vast majority of patients with ESRD not only
can be successfully trained for CAPD but also can be successfully maintained on
CAPD for at least the initial months of therapy. Thus, 22 of 23 new patients with
endstage renal failure seen by our group during the last year have been treated with
CAPD. The patient population treated with CAPD in the present study, including
five patients more than 70 years of age, 14 patients > to 60 years ofage, four patients
with diabetes, one patient with myeloma, and six patients living alone, represents an
unselected population of patients with ESRD and is typical of the more general
population of patients with renal failure [8].
Patient acceptance of CAPD has been uniformly enthusiastic. No patient has
requested to be cared for by an in-center hemodialysis or peritoneal dialysis program.
Only one patient returned to in-center hemodialysis because ofa resistant Pseudomo-
nas peritonitis necessitating catheter removal. Patients have spent minimal time in
hospital; ten patients have not required hospitalization after the placement of their
peritoneal catheters. Furthermore, assessment of the patients' psychological and
general physical status has been most encouraging: our CAPD patients maintained
on therapy for four to 12 months had significantly less depressive and less organic
symptomatology than a group of hemodialysis patients maintained on therapy for a
comparable period of time. In addition the CAPD patients had significantly fewer
physical symptoms than the hemodialysis patients (Table 2).
The expense of government financed programs for the treatment of patients with
ESRD has been the focus of increasing attention recently [14]. In the United States,
TABLE 3
Laboratory Data* of Patients on CAPD 2 4 Months
HCT (%) 28 + 2 Calcium (mg/dl) 9.1 ± 0.4
BUN (mg/dl) 64 t 6 Inorganic Phosphorus (mg/dl) 4.9 + 0.5
Creatinine (mg/dl) 9.9 + 1.3 Triglycerides (mg/dl) 232 + 36
Albumin (g/dl) 3.0 + 0.1 Cholesterol (mg/dl) 222 X 29
Sodium (mEq/L) 139 I Potassium (mEq/L) 4.2 + 0.3
Venous Bicarbonate (mEq/L) 26 + 1
*mean X SE of most current monthly laboratory studies
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the ESRD program consumes 5 percent of the Medicare budget for less than 0.2
percent of the active Medicare population [14]. One problem with the United States
ESRD program has been the declining percentage of patients with endstage renal
failure treated with home dialysis [14]. In European countries, continued home
training has, to some extent, helped curtail the cost ofendstage renaldisease therapy.
Maintaining a patient on CAPD at present costs about $12,000 a year, compared to
$25,000 for in-center hemodialysis and about $10,000 for home hemodialysis. Since
the present study suggests that the vast majority of patients with ESRD can be
successfully trained and maintained on CAPD, the potential cost saving by the wide
application of this therapy may be considerable.
Furthermore, the nature of our training program is of interest and has additional
implications in terms of utilization of health care resources. Training and follow-up
therapyfor all CAPD patients in this studywas provided in a physician-office setting,
with hospital beds being used only for the placement of peritoneal catheters and for
severe complications arising during therapy. The advantages of this type of program
include an efficient utilization ofpersonnel and health care resources, encouragement
of patient independence by distancing them from the hospital, and provision for
more flexibility in training schedules. It must be stressed, however, that for such an
office-based program to be successful, rigorous and thorough care and follow-up
must be provided bydedicated and concerned nurse and physician staffs, available 24
hours a day, seven days a week. In addition, full hospital support with an adequate
number of hospital nurses skilled in peritoneal dialysis techniques must be available
to back up the out-of-hospital facility.
In summary, CAPD can be successfully employed, at leastfor the initial months of
therapy, to treat the vast majority of patients with ESRD. CAPD training and
follow-up care can be provided in an out-of-hospital office facility, if adequate
hospital support is available and the facility is staffed by conscientious personnel.
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